Advertisement

Assessment of Left Ventricular Function by Contrast Echo

  • Peter N Burns
  • Harald Becher

Abstract

Accurate and reproducible quantification of left ventricular (LV) function is a crucial component of clinical cardiology. LV function should be assessed in each cardiac patient. Earlier, research and development of diagnostic measures concentrated on systolic LV function, because diastole was thought to be a passive process, which is now known not to be the case. However, it is still easier to evaluate systolic than diastolic function. In the physiology lab, LV function is assessed using calculations derived from pressure and volume recordings; in clinical cardiology measurement of LIV wall motion has become the usual method for routine invasive and non-invasive diagnostics (1). We distinguish between global and regional systolic function; in order to assess global systolic LV function, quantification of end-diastolic and end-systolic volumes (LVED, LVES) and ejection fraction (EF) is essential. LV volume and ejection fraction are powerful prognostic measures in patients with coronary and valvular heart disease (2).

Keywords

Left Ventricular Function Dobutamine Stress Echocardiography Left Ventricular Cavity Doppler Spectrum Endocardial Border 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schiller NB, Shah PM, Crawford M et al. Recommendations for quantification of the left ventricle by 2-dimensional echocardiography; American Society of Echocardiography committee on standards, subcommittee on quantification of 2-dimensional echocardiograms. J Am Soc Echocardiogr 1989; 2: 358 – 367PubMedGoogle Scholar
  2. 2.
    White HD, Morris RM, Brown MA, Brandt PWT, Whitlick PML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival recovery from myocardial infarction. Circulation 1987; 76: 44 – 51PubMedCrossRefGoogle Scholar
  3. 3.
    Cannon CP, Thompson B, McCabe et al. Predictors of non Q wave acute myocardial infarction in patients with acute ischemic syndroms. An ananlysis from the TIMI III trials. Am J Cardiol 1995; 75: 977 – 981PubMedCrossRefGoogle Scholar
  4. 4.
    Cohen GC, Pietrolungo DO, Thomas JD, Klein AL. A practical guide to assessment of ventricular diastolic function using Doppler echocardiography. J Am Coll Cardiol 1996; 27: 1753 – 60PubMedCrossRefGoogle Scholar
  5. 5.
    Weyman AE,Franklin TD, Egenes KM et al. Correlation between extent of abnormal regional wall motion and myocardial infarct size in chronically infarcted dogs. Circulation 1997; 56: 72 – 78Google Scholar
  6. 6.
    Hoffmann R, Lethen H, Marwick T et al. Analysis of interinstitutional observer agreement in the interpretation of dobutamine stress echocardiography. J Am Coll Cardiol 19996; 27:330–336PubMedCrossRefGoogle Scholar
  7. 7.
    Panza J, Laurienzo M, Curiel RV, Quyumi AA, Cannon RO. Transesophageal. dobutamine stress echocardiography for evaluation of patients with coronary artery disease. J Am Coll Cardiol 1994; 24: 1260 – 1267PubMedCrossRefGoogle Scholar
  8. 8.
    Nagel E, Lehmkuhl HB, Bocksch W et al. Non-invasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999; 99: 763 – 770PubMedGoogle Scholar
  9. 9.
    Ashburn Wl, Schelbert Hr, Verba JW Left ventricular ejection fraction — a review of several radionuclide angiographic approaches using the scintillation camera. Proc cardiovasc Dis 1978; 20: 267 – 284CrossRefGoogle Scholar
  10. 10.
    Schad N. The intermittend phased injection of contrast material into the heart. Am J Roentgen 1968; 104: 464PubMedGoogle Scholar
  11. 10.
    Schad N. The intermittend phased injection of contrast material into the heart. Am J Roentgen 1968; 104: 464PubMedGoogle Scholar
  12. 12.
    Cohen JL, Cheirif J, Segar DS, Gillam LD, Gottdiener JS, Hausnerova E, Bruns DE. Improved left ventricular endocardial. border delineation and opacification with Optison, a new echocardiography contrast agent. Results of a Phase III multicenter trial. J Am Coll Cardiol 1998; 32 (3): 746 – 752PubMedCrossRefGoogle Scholar
  13. 13.
    Crouse LJ, Cheirif J, Hanly DE et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the phase III Albunex multicenter trial. J Am Coll Cardiol 1993; 22: 1494 – 1500PubMedCrossRefGoogle Scholar
  14. 14.
    Feinstein SB, Cheirif J, Ten Cate FJ et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results. J Am Coll Cardiol 1990; 16: 316 – 324PubMedCrossRefGoogle Scholar
  15. 15.
    Grayburn PA, Weiss JL, Hakc TC et al. Phase 3 multi center trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echo cardiograms. J Am Coll Cardiol 1998; 32: 230 – 236PubMedCrossRefGoogle Scholar
  16. 16.
    Mulvagh SL, Rainbird AJ, Al-Mansour HA et al. Harmonic dobutamine stress echocardiography: Does contrast make a difference in diagnostic feasability and accuracy? Circulation 1998; 12. 527Google Scholar
  17. 17.
    Becher H, Tiemann K, Schlosser T, Pohl C, Nanda NC, Averkiou M, Powers J, Lüderitz B. Improvement of endocardial border delineation using tissue harmonic imaging. Echocardiography 1998; 15 (5): 511 – 516PubMedCrossRefGoogle Scholar
  18. 18.
    Rakowski H., Appleton C, Chan KW et al. Canadien consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography. J Am Soc Echocardiogr 1996; 9: 736 – 760PubMedCrossRefGoogle Scholar
  19. 19.
    van Bibra H, Sutherland G, Becher H, Neudert J, Nihoyannopoulos P. Clinical evaluation of left heart Doppler contrast enhancement by a saccharide-based transpulmonary contrast agent. The Levovist Cardiac Working Group. J Am Coll Cordial 1995; 25 (2): 500 – 508CrossRefGoogle Scholar
  20. 20.
    Lambertz H, Schumacher U, Tries HP, Stein T. Improvement of pulmonary venous flow Doppler signal after intravenous injection of Levovist. J Am Soc Echocardiogr 1997; 10: 891 – 8PubMedCrossRefGoogle Scholar
  21. 21.
    Thanigaraj, S, Perez JE. Image enhancement with second generation contrast agents improve diagnostic accuracy and reduces additional testing. J Am Soc Echocardiogr 1999; 12: 366CrossRefGoogle Scholar
  22. 22.
    Porter TR, Xie F, Kricsfeld A, Chiou A, Dabestani A. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. J Am Coll Cardiol 1994; 23: 1440 – 1443PubMedCrossRefGoogle Scholar
  23. 23.
    Thanigaraj S, Schlechtman KB, Perez JE. Improved echocardiography delineation of left ventricular thrombus with use of intravenous second-generation-contrast image enhancement. J Am Soc Echocardiogr 1999; 12: 1022 – 1026PubMedCrossRefGoogle Scholar
  24. 24.
    Roberto M. Lang, M.D., James Bednarz, B.S., RDCS, Victor Mor-Avi, Ph.D., Kirk T. Spencer, M.D.J Am Soc Echocardiogr 1999; 12: 871 – 5PubMedCrossRefGoogle Scholar
  25. 25.
    Burns, RN. (1995). Hemodynamics. In K. J. W Taylor, P N. Burns, & P. N. T. Wells (Eds.), Clinical Applications of Doppler Ultrasound (pp. 35 – 55 ). New York: Raven PressGoogle Scholar
  26. 26.
    Bezante G, Schwarz KQ, Chen X, Bertolazzi M, Spallarosa P, Villa G, Brunelli C. Automatic LV volume and ejection fraction by contrast harmonic color Doppler imaging compared to radionuclide ventriculography Eur Heart J 1999; 3628Google Scholar
  27. 27.
    Caiati C, Bina A, Zedda N et al. Contrast-enhanced harmonic colour Doppler reduces variability in assessing left ventricular volumes. Eur Heart J 1998; 19 (abstract supplement): 2350Google Scholar
  28. 28.
    Becher H, Tiemann K, Schlief R, Nanda N. Harmonic Power Doppler Contrast Echocardiography: preliminary clinical results (1997) Echocardiography 14; 6:637–642CrossRefGoogle Scholar

Copyright information

© Harald Becher and Peter N Burns 2000

Authors and Affiliations

  • Peter N Burns
    • 1
  • Harald Becher
    • 2
  1. 1.Imaging Research Sunnybrook and Women’s Health Science CentreUniversity of TorontoTorontoCanada
  2. 2.Rheinische Friedrich-Wilhelms-Universität Medizinische Universitätsklink und Poliklink II Kardiologie/PneumologieUniversity of BonnBonnGermany

Personalised recommendations